Candriam SCA’s Kura Oncology KURA Stock Holding History

Candriam SCA’s Portfolio KURA Stock Details KURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-422,652	Closed	-$2.79M	–	703
2025 Q1	$2.79M	Hold	422,652	–	–	0.02%	441
2024 Q4	$3.68M	Sell	422,652 -483,830	-53%	-$4.21M	0.02%	401
2024 Q3	$17.7M	Hold	906,482	–	–	0.1%	198
2024 Q2	$18.7M	Buy	906,482 +255,065	+39%	+$5.25M	0.11%	184
2024 Q1	$13.9M	Buy	651,417 +110,000	+20%	+$2.35M	0.09%	214
2023 Q4	$7.79M	Sell	541,417 -150,005	-22%	-$2.16M	0.05%	286
2023 Q3	$6.31M	Hold	691,422	–	–	0.04%	289
2023 Q2	$7.32M	Sell	691,422 -122,942	-15%	-$1.3M	0.05%	287
2023 Q1	$9.17M	Hold	814,364	–	–	0.06%	270
2022 Q4	$10.1M	Buy	814,364 +118,789	+17%	+$1.47M	0.07%	275
2022 Q3	$9.5M	Buy	695,575 +257,260	+59%	+$3.51M	0.07%	283
2022 Q2	$8.03M	Hold	438,315	–	–	0.07%	261
2022 Q1	$7.05M	Sell	438,315 -469,118	-52%	-$7.54M	0.05%	301
2021 Q4	$12.7M	Sell	907,433 -38,924	-4%	-$545K	0.08%	230
2021 Q3	$17.7M	Hold	946,357	–	–	0.12%	194
2021 Q2	$19.7M	Buy	946,357 +17,080	+2%	+$356K	0.14%	178
2021 Q1	$29.2M	Sell	929,277 -5	-0%	-$157	0.24%	108
2020 Q4	$30.4M	Buy	929,282 +390,086	+72%	+$12.7M	0.24%	108
2020 Q3	$16.5M	Buy	539,196 +299,492	+125%	+$9.18M	0.16%	156
2020 Q2	$3.91M	Buy	+239,704	New	+$3.91M	0.04%	383
2019 Q4	–	Sell	-138,100	Closed	-$2.1M	–	800
2019 Q3	$2.1M	Sell	138,100 -224,000	-62%	-$3.4M	0.03%	476
2019 Q2	$7.1M	Sell	362,100 -33,900	-9%	-$665K	0.09%	254
2019 Q1	$6.57M	Buy	396,000 +30,000	+8%	+$498K	0.08%	266
2018 Q4	$5.14M	Hold	366,000	–	–	0.08%	279
2018 Q3	$6.41M	Sell	366,000 -16,000	-4%	-$280K	0.09%	272
2018 Q2	$6.95M	Sell	382,000 -3,000	-0.8%	-$54.6K	0.11%	233
2018 Q1	$7.22M	Sell	385,000 -130,000	-25%	-$2.44M	0.12%	212
2017 Q4	$7.88M	Sell	515,000 -25,000	-5%	-$383K	0.14%	189
2017 Q3	$8.07M	Buy	+540,000	New	+$8.07M	0.14%	178